The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.

Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results.

Investigational New Drugs cuts across all the usual lines or subdisciplines, providing a locus for the presentation of relevant investigations and the discussion of critical questions appropriate to the entire field of new anticancer drug development.

Editor-in-Chief:
Eric K. Rowinsky
New York, NY, USA
Founding Editor & Associate Editor: Daniel Von Hoff, Tucson, AZ, USA

Associate Editors: 
Todd Fehniger, St. Louis, MO, USA
David Hong, Houston, TX, USA
Razelle Kurzrock, San Diego, CA, USA
John Miller, Wellington, New Zealand
Eric Raymond, Clichy, France
Gary Schwartz, New York, NY, USA

Editorial Advisory Board:

Julie R. Brahmer, Baltimore, MD, USA
Emiliano Calvo, Madrid, Spain
Richard D. Carvajal,New York, NY, USA
Samuel R. Denmeade, Baltimore, MD, USA
Antoine Italiano, Bordeaux, France
Patricia M. LoRusso, New Haven, CT, USA
Christophe Massard, Villejuif, France
Gary William Middleton, Birmingham, UK
Alain Mita, Los Angeles, CA, USA
Monica Mita, Los Angeles, CA, USA
Sun Young Rha, Seoul, Korea
Manish Sharma, Chicago, IL, USA
Anil Sood, Houston, TX, USA
Alex Sparreboom, Columbus, OH, USA
Josep Tabernero, Barcelona, Spain
Timothy Yap, London, UK